PDLI
PDL Biopharma Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
Market Cap: 296 Million
Primary Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET)
Website: http://pdl.com/
Shares Outstanding: 114 Million
Float: 0
Dividend: 0.07096252269049486 (0.03%)
Beta: 0.7382132027243871
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Ethical Flags
Longest drawdown: 1682 trading days
From: 2014-09-02 To: 2020-11-27
Lowest Point:
Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors
via: PR Newswire at 2019-06-10 12:01:00:000
SAN DIEGO and INCLINE VILLAGE, Nev. , June 10, 2019 /PRNewswire/ --Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, and PDL BioPharma, Inc. (Nasdaq: PDLI) (PDL) today announced the closing of the second tranche for $50 million of an a… read more...
Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors
via: PR Newswire at 2019-06-10 12:01:00:000
SAN DIEGO and INCLINE VILLAGE, Nev. , June 10, 2019 /PRNewswire/ --Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, and PDL BioPharma, Inc. (Nasdaq: PDLI) (PDL) today announced the closing of the second tranche for $50 million of an a… read more...
Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors
via: PR Newswire at 2019-06-10 12:01:00:000
SAN DIEGO and INCLINE VILLAGE, Nev. , June 10, 2019 /PRNewswire/ --Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, and PDL BioPharma, Inc. (Nasdaq: PDLI) (PDL) today announced the closing of the second tranche for $50 million of an a… read more...
Evofem Biosciences Closes $80 Million Financing Transaction with PDL BioPharma and Other Long-time Investors
via: PR Newswire at 2019-06-10 12:01:00:000
SAN DIEGO and INCLINE VILLAGE, Nev. , June 10, 2019 /PRNewswire/ --Evofem Biosciences, Inc. (NASDAQ: EVFM) (Evofem), a clinical-stage biopharmaceutical company, and PDL BioPharma, Inc. (Nasdaq: PDLI) (PDL) today announced the closing of the second tranche for $50 million of an a… read more...
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|---|---|---|---|---|---|---|---|
2016-06-02 | 2016-06-13 | 2016-06-06 | 2016-05-04 | 0.05 | No Change QoQ | |||
2016-03-02 | 2016-03-11 | 2016-03-04 | 2016-02-01 | 0.05 | Decrease | |||
2015-12-02 | 2015-12-11 | 2015-12-04 | 2015-01-29 | 0.15 | No Change QoQ | |||
2015-09-02 | 2015-09-11 | 2015-09-04 | 2015-01-29 | 0.15 | No Change QoQ | |||
2015-06-03 | 2015-06-12 | 2015-06-05 | 2015-01-29 | 0.15 | No Change QoQ | |||
2015-03-03 | 2015-03-12 | 2015-03-05 | 2015-01-29 | 0.15 | No Change QoQ | |||
2014-12-03 | 2014-12-12 | 2014-12-05 | 2014-01-30 | 0.15 | No Change QoQ | |||
2020-09-21 | 2020-10-01 | 2020-09-22 | 2020-09-10 | 0.075879 | Cash |
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|